Literature DB >> 2998996

Cytogenetics of Burkitt's lymphoma-leukaemia: a review.

R Berger, A Bernheim.   

Abstract

Two types of chromosomal abnormality have been found in Burkitt's lymphoma-leukaemia. Three specific translocations, t(8;14), t(8;22) and t(2;8), having in common 8q24 band involvement, are thought to be present in the overwhelming majority of cases. These stereotyped translocations have been shown in many cases to be related to DNA molecular rearrangements of the immunoglobulin genes and the c-myc oncogene. Secondary chromosomal abnormalities, some of them nonrandom, have also been described. Their possible relation to other oncogene involvement and to the Epstein-Barr virus genome is discussed.

Entities:  

Mesh：

Year:  1985        PMID： 2998996

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN： 0300-5038


  5 in total

1.  Secondary abnormalities involving 1q or 13q and poor outcome in high stage Burkitt leukemia/lymphoma cases with 8q24 rearrangement at diagnosis.

Authors:  Mariana Tavares de Souza; Hasmik Mkrtchyan; Rocio Hassan; Daniela Ribeiro Ney-Garcia; Alice Maria Boulhosa de Azevedo; Elaine Sobral da Costa; Amanda Faria de Figueiredo; Thomas Liehr; Eliana Abdelhay; Maria Luiza Macedo Silva
Journal:  Int J Hematol       Date:  2011-01-05       Impact factor: 2.490

2.  Establishment and characterisation of an Epstein-Barr virus negative B immunoblastic lymphoma cell line.

Authors:  Y S Ho; L F Sheu; J A Ng; S M Hsu
Journal:  Br J Cancer       Date:  1990-05       Impact factor: 7.640

3.  High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma.

Authors:  Saloua Toujani; Philippe Dessen; Nathalie Ithzar; Gisèle Danglot; Catherine Richon; Yegor Vassetzky; Thomas Robert; Vladimir Lazar; Jacques Bosq; Lydie Da Costa; Christine Pérot; Vincent Ribrag; Catherine Patte; Jöelle Wiels; Alain Bernheim
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

4.  Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

Authors:  H A Poirel; M S Cairo; N A Heerema; J Swansbury; A Aupérin; E Launay; W G Sanger; P Talley; S L Perkins; M Raphaël; K McCarthy; R Sposto; M Gerrard; A Bernheim; C Patte
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

5.  Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease.

Authors:  Matthew J Johnson; Kanut Laoharawee; Walker S Lahr; Beau R Webber; Branden S Moriarity
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.